DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

Announcement on Conversion Result of Convertible Bonds and Share Changes

Apr 3, 2026 · Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 3, 2026

On 6ix: 6ix.com/news/announcement-on-conversion-result-of-convertible-bonds-and-share-changes-56

Announcement on Conversion Result of Convertible Bonds and Share Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Earlier from DaShenLin Pharmaceutical

Announcement on the Completion of Board of Directors Re-election and the Election of Company Chairman, Members of Special Committees under the Board of Directors, as well as the Appointment of Senior Management Member and Securities Affairs RepresentativeApr 1
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026Mar 31
Announcement on Election of Board of Directors at Expiry of Term of OfficeMar 14
Announcement on Release of Pledge of Partial Shares of Controlling ShareholdersDec 20, 2025
Announcement on Convening the Q3 2025 Performance BriefingDec 2, 2025

Later from DaShenLin Pharmaceutical

Announcement on Resolutions of the 2nd Meeting of the 5th Board of DirectorsApr 24
Announcement on Convening Performance Briefing for 2025 and Q1 2026May 9
Indicative Announcement on Change of the Meeting Date of the 2025 Annual General MeetingMay 12
Announcement on Resolutions of the 2025 Annual General MeetingMay 19
Indicative Announcement on Impending Expiration of 2020 Employee Stock Ownership PlanMay 28

All DaShenLin Pharmaceutical news releases

Follow DaShenLin Pharmaceutical into a list and get an email when it puts out news.

Follow DaShenLin Pharmaceutical